Spanish Dx Firm Imegen Acquired in €10M Private Equity Buyout

Mar 20, 2017

|

NEW YORK (GenomeWeb) – Spanish diagnostics company Imegen has been acquired by private equity investors for €10 million ($10.8 million), according to a European news report which the company has confirmed.

Q-Growth Fund and Biolty bought out 41 of the 42 shareholders in the Valencia, Spain-based firm. The investors are also Spanish firms.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Menu

Spanish Dx Firm Imegen Acquired in €10M Private Equity Buyout

To read the full story....

Breaking News

Zymo Research Gets CE-IVD Mark for Sample Collection Devices

Angle Files De Novo FDA Submission for CTC Collection Device in Breast Cancer

LabCorp, Genfit Partner to Commercialize Liver Disease Diagnostic Test

FDA Reissues Emergency Use Authorization for Hologic SARS-CoV-2 Assay for Asymptomatic Testing

Quotient Limited Gets FDA Emergency Use Authorization for Coronavirus Antibody Test

Palmetto Expands Coverage for Decipher Biosciences Prostate Cancer Test

Featured White Papers

Moving from Non-Invasive Prenatal Screening to Prenatal Diagnostics: An Expert Panel Discussion

Navigating the FDA's EUA Process for Diagnostics in the Present and Future: A Stakeholder Panel Discussion

What's Popular?

Cepheid Multiplex SARS-CoV-2, Flu, RSV Test Nabs FDA Emergency Use Authorization

FDA Reissues Emergency Use Authorization for Hologic SARS-CoV-2 Assay for Asymptomatic Testing

ASU Team Wins $6M in Government Funding to Develop Rapid Saliva Testing System for Coronavirus

Israeli Startup LessTests Uses Single-Step Pooling Software to Multiply COVID-19 Testing Capacity

Abacus Diagnostica Readying Multiplex RT-PCR Test for SARS-CoV-2, Flu, RSV

Sponsorships